Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42

ACS Chemical Neuroscience
Tanja WeiffertSara Linse

Abstract

Aggregation of the amyloid-β (Aβ) peptide into plaques is believed to play a crucial role in Alzheimer's disease. Amyloid plaques consist of fibrils of full length Aβ peptides as well as N-terminally truncated species. β-Site amyloid precursor protein-cleaving enzyme (BACE1) cleaves amyloid precursor protein in the first step in Aβ peptide production and is an attractive therapeutic target to limit Aβ generation. Inhibition of BACE1, however, induces a unique pattern of Aβ peptides with increased levels of N-terminally truncated Aβ peptides starting at position 5 (Aβ5-X), indicating that these peptides are generated through a BACE1-independent pathway. Here we elucidate the aggregation mechanism of Aβ5-42 and its influence on full-length Aβ42. We find that, compared to Aβ42, Aβ5-42 is more aggregation prone and displays enhanced nucleation rates. Aβ5-42 oligomers cause nonspecific membrane disruption to similar extent as Aβ42 but appear at earlier time points in the aggregation reaction. Noteworthy, this implies similar toxicity of Aβ42 and Aβ5-42 and the toxic species are generated faster by Aβ5-42. The increased rate of secondary nucleation on the surface of existing fibrils originates from a higher affinity of Aβ5-42 monomer...Continue Reading

References

Apr 10, 1992·Science·J A Hardy, G A Higgins
Oct 13, 1995·The Journal of Biological Chemistry·C J PikeC W Cotman
Dec 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Gal BitanDavid B Teplow
Jan 4, 2003·Nature Reviews. Neuroscience·Claudio Soto
Jul 4, 2003·The Journal of Biological Chemistry·Gal BitanDavid B Teplow
Dec 8, 2004·Proceedings of the National Academy of Sciences of the United States of America·B UrbancH E Stanley
Jul 25, 2008·The Journal of Biological Chemistry·Harald SteinerChristian Haass
Nov 18, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Patrick C MayJames E Audia
Jan 31, 2012·Nature Neuroscience·Iryna BenilovaBart De Strooper
Jun 30, 2012·Nature Methods·Johannes SchindelinAlbert Cardona
Aug 14, 2012·Journal of Alzheimer's Disease : JAD·Erik PorteliusHenrik Zetterberg
May 25, 2013·Proceedings of the National Academy of Sciences of the United States of America·Samuel I A CohenTuomas P J Knowles
Jun 19, 2014·Proceedings of the National Academy of Sciences of the United States of America·Georg MeislTuomas P J Knowles
Jan 27, 2015·Alzheimer's Research & Therapy·Robert Vassar
Nov 5, 2015·Journal of the American Chemical Society·Olga SzczepankiewiczSara Linse
Jan 8, 2016·Nature Protocols·Georg MeislTuomas P J Knowles
Jan 1, 2015·Nature Reviews. Disease Primers·Colin L MastersJeffrey L Cummings
Jun 28, 2016·Scientific Reports·Marija IljinaDavid Klenerman
Aug 31, 2016·Proceedings of the National Academy of Sciences of the United States of America·Patrick FlagmeierCéline Galvagnion
Sep 14, 2016·Proceedings of the National Academy of Sciences of the United States of America·Montserrat Serra-BatisteNatàlia Carulla
May 6, 2017·Angewandte Chemie·Patrick FlagmeierDavid Klenerman
Aug 27, 2017·Scientific Reports·Norelle C WildburgerDavid L Brody
May 3, 2018·The New England Journal of Medicine·Michael F EganDavid Michelson
Jun 14, 2018·Proceedings of the National Academy of Sciences of the United States of America·Xiaoting YangSara Linse

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Samuel I A CohenTuomas P J Knowles
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Anna L SternKelly L Jordan-Sciutto
© 2022 Meta ULC. All rights reserved